Keyphrases
Peripheral Neuropathy
100%
Combined Antiretroviral Therapy (cART)
100%
High Iron
100%
Iron Stores
100%
Neuropathy
75%
People Living with HIV (PLHIV)
62%
High-sensitivity C-reactive Protein (hs-CRP)
50%
Transferrin Receptor 1 (TfR1)
50%
Neuropathic Pain
37%
Ferritin
25%
White People
25%
C-reactive Protein Level
25%
Regression Model
12%
Risk Reduction
12%
Genetic Studies
12%
Genotype
12%
Gene Variants
12%
Group Studies
12%
Delayed Onset
12%
Potential Confounders
12%
Low-resource Settings
12%
AIDS Clinical Trials
12%
HIV+
12%
Sensory Neuropathy
12%
Proportional Hazards Model
12%
Antiviral Drugs
12%
Iron Deficiency
12%
Non-carriers
12%
Time-to-event
12%
Time-to-event Analysis
12%
Hemochromatosis
12%
Iron Levels
12%
HFE Gene
12%
Iron Loading
12%
Therapy Strategy
12%
Multicenter Randomized Clinical Trial
12%
HFE Variants
12%
Delayed Neuropathy
12%
Medicine and Dentistry
Neuropathy
100%
Antiretroviral Therapy
100%
Iron Storage
100%
Human Immunodeficiency Virus
75%
C Reactive Protein
50%
Iron
50%
Transferrin Receptor
50%
Iron Deficiency
25%
Ferritin
25%
Clinical Trial
12%
Randomized Clinical Trial
12%
Hemochromatosis
12%
Neuropathic Pain
12%
Sensory Neuropathy
12%
Pharmacology, Toxicology and Pharmaceutical Science
Neuropathy
100%
Iron
100%
HIV
75%
C Reactive Protein
50%
Transferrin Receptor
50%
Iron Deficiency
25%
Ferritin
25%
Clinical Trial
12%
Randomized Clinical Trial
12%
Neuropathic Pain
12%
Sensory Neuropathy
12%
Hemochromatosis
12%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Iron Storage
100%
C-Reactive Protein
66%
Ferritin
33%